Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

Marjatta Leirisalo-Repo; Hannu Kautiainen; Leena Laasonen; Markku Korpela; Markku J. Kauppi; Oili Kaipiainen-Seppanen; Riitta Anneli Luosujärvi; Reijo Luukkainen; Anna Karjalainen; Harri Blafield; Toini Uutela; Kirsti Ilva; Heikki A. Julkunen; Leena Paimela; Kari Puolakka; Eeva Moilanen; Pekka J. Hannonen; Timo Mottonen; NEO-RACo Study Grp

doi:10.1136/annrheumdis-2012-201365

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

Marjatta Leirisalo-Repo, Hannu Kautiainen, Leena Laasonen, Markku Korpela, Markku J. Kauppi, Oili Kaipiainen-Seppanen, Riitta Anneli Luosujärvi, Reijo Luukkainen, Anna Karjalainen, Harri Blafield, Toini Uutela, Kirsti Ilva, Heikki A. Julkunen, Leena Paimela, Kari Puolakka, Eeva Moilanen, Pekka J. Hannonen, Timo Mottonen, NEO-RACo Study Grp

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	72
Issue number	6
Pages (from-to)	851-857
Number of pages	7
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2012-201365
Publication status	Published - Jun 2013
MoE publication type	A1 Journal article-refereed

Fields of Science

MODIFYING ANTIRHEUMATIC DRUGS
CONTROLLED-TRIAL
METHOTREXATE MONOTHERAPY
DISEASE-ACTIVITY
CLINICAL-TRIALS
TIGHT CONTROL
FOLLOW-UP
REMISSION
SULFASALAZINE
ETANERCEPT
3121 General medicine, internal medicine and other clinical medicine

Access to Document

10.1136/annrheumdis-2012-201365

Cite this

Leirisalo-Repo, M., Kautiainen, H., Laasonen, L., Korpela, M., Kauppi, M. J., Kaipiainen-Seppanen, O., Luosujärvi, R. A., Luukkainen, R., Karjalainen, A., Blafield, H., Uutela, T., Ilva, K., Julkunen, H. A., Paimela, L., Puolakka, K., Moilanen, E., Hannonen, P. J., Mottonen, T., & NEO-RACo Study Grp (2013). Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study). Annals of the Rheumatic Diseases, 72(6), 851-857. https://doi.org/10.1136/annrheumdis-2012-201365

@article{84e910170d5b48f08441a117a7b3e2b5,

title = "Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)",

keywords = "MODIFYING ANTIRHEUMATIC DRUGS, CONTROLLED-TRIAL, METHOTREXATE MONOTHERAPY, DISEASE-ACTIVITY, CLINICAL-TRIALS, TIGHT CONTROL, FOLLOW-UP, REMISSION, SULFASALAZINE, ETANERCEPT, 3121 General medicine, internal medicine and other clinical medicine",

author = "Marjatta Leirisalo-Repo and Hannu Kautiainen and Leena Laasonen and Markku Korpela and Kauppi, {Markku J.} and Oili Kaipiainen-Seppanen and Luosuj{\"a}rvi, {Riitta Anneli} and Reijo Luukkainen and Anna Karjalainen and Harri Blafield and Toini Uutela and Kirsti Ilva and Julkunen, {Heikki A.} and Leena Paimela and Kari Puolakka and Eeva Moilanen and Hannonen, {Pekka J.} and Timo Mottonen and {NEO-RACo Study Grp}",

year = "2013",

month = jun,

doi = "10.1136/annrheumdis-2012-201365",

language = "English",

volume = "72",

pages = "851--857",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group Ltd",

number = "6",

}

Leirisalo-Repo, M, Kautiainen, H, Laasonen, L, Korpela, M, Kauppi, MJ, Kaipiainen-Seppanen, O, Luosujärvi, RA, Luukkainen, R, Karjalainen, A, Blafield, H, Uutela, T, Ilva, K, Julkunen, HA, Paimela, L, Puolakka, K, Moilanen, E, Hannonen, PJ, Mottonen, T & NEO-RACo Study Grp 2013, 'Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)', Annals of the Rheumatic Diseases, vol. 72, no. 6, pp. 851-857. https://doi.org/10.1136/annrheumdis-2012-201365

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study). / Leirisalo-Repo, Marjatta; Kautiainen, Hannu; Laasonen, Leena et al.

In: Annals of the Rheumatic Diseases, Vol. 72, No. 6, 06.2013, p. 851-857.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

AU - Leirisalo-Repo, Marjatta

AU - Kautiainen, Hannu

AU - Laasonen, Leena

AU - Korpela, Markku

AU - Kauppi, Markku J.

AU - Kaipiainen-Seppanen, Oili

AU - Luosujärvi, Riitta Anneli

AU - Luukkainen, Reijo

AU - Karjalainen, Anna

AU - Blafield, Harri

AU - Uutela, Toini

AU - Ilva, Kirsti

AU - Julkunen, Heikki A.

AU - Paimela, Leena

AU - Puolakka, Kari

AU - Moilanen, Eeva

AU - Hannonen, Pekka J.

AU - Mottonen, Timo

AU - NEO-RACo Study Grp

PY - 2013/6

Y1 - 2013/6

KW - MODIFYING ANTIRHEUMATIC DRUGS

KW - CONTROLLED-TRIAL

KW - METHOTREXATE MONOTHERAPY

KW - DISEASE-ACTIVITY

KW - CLINICAL-TRIALS

KW - TIGHT CONTROL

KW - FOLLOW-UP

KW - REMISSION

KW - SULFASALAZINE

KW - ETANERCEPT

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1136/annrheumdis-2012-201365

DO - 10.1136/annrheumdis-2012-201365

M3 - Article

VL - 72

SP - 851

EP - 857

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 6

ER -

Leirisalo-Repo M, Kautiainen H, Laasonen L, Korpela M, Kauppi MJ, Kaipiainen-Seppanen O et al. Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study). Annals of the Rheumatic Diseases. 2013 Jun;72(6):851-857. doi: 10.1136/annrheumdis-2012-201365